Company UpdateNovember 27, 2024
Coach Jackie Sherrill, President of Celltex Sports Biologics, was featured as a guest columnist in The Bryan-College Station Eagle to share his excitement for the renewed rivalry game between Texas A&M University and the University of Texas.
During Sherrill’s tenure as Texas A&M’s head football coach from 1982 to 1988, the team went 5-2 against Texas. In the article, Coach Sherrill reflects on the past rivalry games and shares what he believes to be the key to winning this year’s Lone Star Showdown.
Learn More
Company UpdateApril 2, 2020
The COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies. On March 21st, 2020, Celltex submitted an emergency expanded access clinical study to the United States Food and Drug Administration (FDA) that would allow patients with COVID-19 to receive infusions of autologous Adipose-tissue derived Mesenchymal Stem Cells (AdMSCs) in the US.
Learn More
Company UpdateMarch 25, 2020
The COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies. The journal Aging & Disease has recently reported on a study that has proven transplantation of mesenchymal stem cells has improved the outcome of 7 patients diagnosed with COVID-19 Pneumonia in Bejing, China.
Learn More
Company UpdateMarch 23, 2020
The COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies. ChinaXiv has performed a recent study that has proven significant improvement of a critically ill COVID-19 patient that was treated with the transfer of human umbilical cord mesenchymal stem cells.
Learn More
Company UpdateMarch 21, 2020
The COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies. Celltex is continuing to monitor and participate in this promising research.
Learn More
